Honap S - Search Results

1

Le Berre C, Honap S, Peyrin-Biroulet L. Le Berre C, et al. Among authors: honap s. Lancet. 2023 Aug 12;402(10401):571-584. doi: 10.1016/S0140-6736(23)00966-2. Lancet. 2023. PMID: 37573077 Review.

2

Smad4 loss is associated with fewer S100A8-positive monocytes in colorectal tumors and attenuated response to S100A8 in colorectal and pancreatic cancer cells.

Ang CW, Nedjadi T, Sheikh AA, Tweedle EM, Tonack S, Honap S, Jenkins RE, Park BK, Schwarte-Waldhoff I, Khattak I, Azadeh B, Dodson A, Kalirai H, Neoptolemos JP, Rooney PS, Costello E. Ang CW, et al. Among authors: honap s. Carcinogenesis. 2010 Sep;31(9):1541-51. doi: 10.1093/carcin/bgq137. Epub 2010 Jul 9. Carcinogenesis. 2010. PMID: 20622003

3

Real-world Effectiveness of Tofacitinib for Moderate to Severe Ulcerative Colitis: A Multicentre UK Experience.

Honap S, Chee D, Chapman TP, Patel M, Kent AJ, Ray S, Sharma E, Kennedy J, Cripps S, Walsh A, Goodhand JR, Ahmad T, Satsangi J, Irving PM, Kennedy NA; LEO [London, Exeter, Oxford] IBD Research Consortium. Honap S, et al. J Crohns Colitis. 2020 Oct 5;14(10):1385-1393. doi: 10.1093/ecco-jcc/jjaa075. J Crohns Colitis. 2020. PMID: 32280965

4

Tofacitinib in Acute Severe Ulcerative Colitis-A Real-World Tertiary Center Experience.

Honap S, Pavlidis P, Ray S, Sharma E, Anderson S, Sanderson JD, Mawdsley J, Samaan MA, Irving PM. Honap S, et al. Inflamm Bowel Dis. 2020 Oct 23;26(11):e147-e149. doi: 10.1093/ibd/izaa157. Inflamm Bowel Dis. 2020. PMID: 32566937 No abstract available.

5

Tofacitinib for the Treatment of Ulcerative Colitis, Alopecia Universalis, and Atopic Dermatitis: One Drug, Three Diseases.

Honap S, Cookson H, Sharma E, Samaan MA, Irving PM. Honap S, et al. Inflamm Bowel Dis. 2021 Jan 19;27(2):e13-e14. doi: 10.1093/ibd/izaa243. Inflamm Bowel Dis. 2021. PMID: 32944765 No abstract available.

6

Response to 'Clinical Efficacy of Tofacitinib in Moderate to Severe Ulcerative Colitis'.

Honap S, Irving PM, Kennedy NA. Honap S, et al. J Crohns Colitis. 2021 Oct 7;15(10):1775-1776. doi: 10.1093/ecco-jcc/jjab080. J Crohns Colitis. 2021. PMID: 34125175 No abstract available.

7

Editorial: is tofacitinib another rescue option for acute severe ulcerative colitis?

Honap S, Pavlidis P, Irving PM. Honap S, et al. Aliment Pharmacol Ther. 2021 Aug;54(3):341-342. doi: 10.1111/apt.16482. Aliment Pharmacol Ther. 2021. PMID: 34236096 No abstract available.

8

Editorial: protecting hypoxia-inducible factor-1α and gut integrity with GB004-a promising therapeutic approach for ulcerative colitis?

Honap S, Dart RJ, Samaan MA. Honap S, et al. Aliment Pharmacol Ther. 2022 Mar;55(6):733-734. doi: 10.1111/apt.16761. Aliment Pharmacol Ther. 2022. PMID: 35245958 No abstract available.

9

Ustekinumab-Induced Inflammatory Demyelinating Polyneuropathy in a Patient with Ulcerative Colitis.

Honap S, Irving PM, Samaan MA. Honap S, et al. J Crohns Colitis. 2023 Jan 27;17(1):144-145. doi: 10.1093/ecco-jcc/jjac116. J Crohns Colitis. 2023. PMID: 35961007 No abstract available.

10

Patient and Public Involvement in Research: Lessons for Inflammatory Bowel Disease.

Honap S, Buisson A, Danese S, Beaugerie L, Peyrin-Biroulet L. Honap S, et al. J Crohns Colitis. 2023 Nov 24;17(11):1882-1891. doi: 10.1093/ecco-jcc/jjad090. J Crohns Colitis. 2023. PMID: 37220886 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

49 results

Search Page

Filters